Lesinurad

A phase 2, multiple-dose, pharmacokinetic and pharmacodynamic study of RDEA594 in patients with hyperuricemia and gout with renal insufficiency

A phase 1, randomized, open-label, crossover study in healthy adult male subjects to assess the relative bioavailability of lesinurad tablets manufactured at two different sites

A phase 1 study to evaluate the potential pharmacokinetic interaction between lesinurad and sildenafil in healthy adult male volunteers

A phase 1, open-label, drug-drug interaction study to evaluate the potential effects of ranitidine on the pharmacokinetics of lesinurad in healthy adult male subjects

A Long-term extension study of lesinurad in combination with febuxostat for subjects with gout completing an efficacy and safety study of lesinurad and febuxostat